Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Naxpar Pharma Private Limited, is an unlisted private company incorporated on 10 February, 2004. It is classified as a private limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 5.00 cr and the total paid-up capital is INR 5.00 cr.
Naxpar Pharma's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 108.46% over the previous year. At the same time, it's book networth has increased by 20.12%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Mihir Prakash Shah
Shareholder
|
00387912 | 21 years |
Whole-time Director | Baiju Mahasukhlal Shah
Shareholder
|
00440806 | 21 years |
Whole-time Director | Prakash Mahasukhlal Shah
Shareholder
|
00440980 | 21 years |
Director | Yogesh Kantilal Varia | 09186184 | 4 years |
Director | Harish Sunderlal Panpalia | 10275561 | 2 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
APNA SAHAKARI BANK LTD
No. of Loans: 9
Total Amount : 72.7 cr
Kotak Mahindra Bank Limited
No. of Loans: 3
Total Amount : 33.8 cr
HDFC Bank Limited
No. of Loans: 5
Total Amount : 15.4 cr
APNA SAHAKARI BANK LIMITED
No. of Loans: 1
Total Amount : 1.0 cr
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SEEZZAM PHARMA PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
NOVOMED PHARMA PVT. LTD |
Active
|
1.0 L | 1 | Maharashtra |
PARNAX LAB PRIVATE LIMITED |
Amalgamated
|
69.0 L | 2 | Maharashtra |
PARNAX LAB LIMITED |
Active
|
11.5 Cr | 3 | Maharashtra |
NAXPAR LAB PVT LTD |
Amalgamated
|
70.0 L | 2 | Maharashtra |
Read more
The incorporation date of NAXPAR PHARMA PRIVATE LIMITED is 10 February, 2004
The authorized share capital of NAXPAR PHARMA PRIVATE LIMITED is INR ₹ 5.0 Cr.
The paid-up capital of NAXPAR PHARMA PRIVATE LIMITED is INR ₹ 5.0 Cr.
The registered address of NAXPAR PHARMA PRIVATE LIMITED is 104-107BLDG NO 8 JOGANI IND COMPLEX CHUNABHATTI MUMBAI Maharashtra - 400022
The CIN number of NAXPAR PHARMA PRIVATE LIMITED is U52310MH2004PTC144449.